Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank65
3Y CAGR-15.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-15.6%/yr
Quarterly compound
Percentile
P65
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.64% |
| Q3 2025 | 0.09% |
| Q2 2025 | 32.45% |
| Q1 2025 | -25.69% |
| Q4 2024 | 7.30% |
| Q3 2024 | 16.01% |
| Q2 2024 | 17.60% |
| Q1 2024 | -30.72% |
| Q4 2023 | 7.25% |
| Q3 2023 | 9.85% |
| Q2 2023 | 13.44% |
| Q1 2023 | -33.54% |
| Q4 2022 | 17.69% |
| Q3 2022 | -8.36% |
| Q2 2022 | 11.57% |
| Q1 2022 | -75.91% |
| Q4 2021 | 1.86% |
| Q3 2021 | -38.59% |
| Q2 2021 | 23.88% |
| Q1 2021 | -51.80% |
| Q4 2020 | -9.09% |
| Q3 2020 | -31.07% |
| Q2 2020 | 11.70% |
| Q1 2020 | 0.00% |